Waters B L
Department of Pathology and Laboratory Medicine, Fletcher Allen Health Care, Burlington, VT 05401, USA.
Pediatr Dev Pathol. 1998 Jan-Feb;1(1):74-8. doi: 10.1007/s100249900009.
Fibrosing colonopathy, characterized by dense submucosal fibrosis in the large bowel, is a disorder associated with bowel dysfunction in patients with cystic fibrosis who receive pancreatic enzyme supplementation. Most commonly, patients present with a distended abdomen and abdominal pain. Radiographs frequently demonstrate colonic wall thickening and luminal narrowing. Here I describe a neonate with cystic fibrosis who presented with both clinical and histological features of fibrosing colonopathy who had not received pancreatic enzymes. This report expands our understanding of the pathogenesis of fibrosing colonopathy.
纤维性结肠病,其特征为大肠黏膜下致密纤维化,是一种与接受胰酶补充治疗的囊性纤维化患者肠道功能障碍相关的疾病。最常见的情况是,患者表现为腹部膨隆和腹痛。X线片常显示结肠壁增厚和管腔狭窄。在此,我描述一名患有囊性纤维化的新生儿,其表现出纤维性结肠病的临床和组织学特征,但未接受过胰酶治疗。本报告扩展了我们对纤维性结肠病发病机制的认识。